N.Y. postpones opioid bellwether trial amid COVID-19 concerns by Kyle Blankenship Wednesday, March 11, 2020 The state of New York will delay a key opioid bellwether trial in a move that could free drugmakers to aggressively pursue global settlements.
Distributor stops opioid sales after being hit with $20M penalty by Eric Palmer Wednesday, January 15, 2020 A New York drug distributor will no longer sell opioids, saying the legal costs associated with them are just too high.
McCann Health taps Cannes Lion award winner as new creative exec by Beth Snyder Bulik Friday, December 27, 2019 McCann Health has hired Tim Jones, award-winning creative, as executive creative director for its New York office.
ViiV's award-winning HIV theater show set for New York run by Beth Snyder Bulik Tuesday, September 10, 2019 ViiV Healthcare’s award-winning theatrical performance about the real-life experiences of black gay men living with HIV debuts in New York this week.
Pfizer pays $700K to settle copay coupon probe by Angus Liu Friday, October 12, 2018 Pfizer will pay $700,000 to settle New York AG charges that it misled consumers with "pay no more than" copay coupons.
First U.S.-Cuba biotech JV debuts with cancer vaccines by Angus Liu Monday, October 1, 2018 Roswell Park Comprehensive Cancer Center has announced a biotech joint venture with Havana-based Center for Molecular Immunology.
Merck, Novartis discrimination suits reignite public attention by Angus Liu Thursday, June 28, 2018 A lawsuit against Merck alleges the company discriminated against female sales reps while the lead plaintiffs also pursue their own pregnancy discrimination allegations.
Groundwork underway for Athenex $200M New York plant by Joseph Keenan Tuesday, May 29, 2018 Athenex has begun site preparation for its $200 million manufacturing facility in Dunkirk, New York.
Pfizer plants its new HQ flag at The Spiral with a view by Tracy Staton Tuesday, April 10, 2018 It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral.
Sen. Sanders wants more from Congress on opioid issue by Eric Sagonowsky Tuesday, February 6, 2018 Sen. Sanders said it's time for Congress to force CEOs to testify on the opioid crisis as lawyers negotiate a potential settlement.
